RecruitingNot ApplicableNCT06183684
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Sponsor
Laplace Interventional, Inc
Enrollment
65 participants
Start Date
Feb 19, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Eligibility
Min Age: 18 YearsMax Age: 90 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a medical device called Laplace TTVR System for people with tricuspid regurgitation. The study is currently recruiting participants at 6 locations. People eligible for this study include aged 22 Years to 90 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICELaplace TTVR System
Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of severe, symptomatic tricuspid regurgitation
Locations(10)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06183684
Related Trials
Laplace Early Feasibility Study - Canada
NCT071710603 locations
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NCT0409714579 locations
TTVR Early Feasibility Study
NCT0443306520 locations
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
NCT055564602 locations
EFS of the DUO System for Tricuspid Regurgitation
NCT0591390815 locations